Athenex, Inc. 4/A SEC Filings

Filed On	Filing
06 May 2022	Form 4/A: Lau Johnson Yiu Nam, Director Received 23,516 shares as a grant or award ($11.4K)
16 Sep 2020	Form 4/A: Davis Stephanie A, Director Bought 10,000 shares ($114K)
21 Aug 2018	Form 4/A: Zukin James, See Remarks Granted 19,500 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Riehle J Nick, See Remarks Granted 120,000 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Cannon Michael D, See Remarks Granted 18,000 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Zuo William Wei, President, China Division Granted 1 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Zhang Song-Yi, Director and 3 others Granted 28,500 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Yordon Jeffrey, See Remarks Granted 230,000 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Wu Jinn, Director Granted 28,500 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Trainor-Degirolamo Sheldon, Director Granted 19,500 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Pedder Simon, See Remarks Granted 130,000 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Lau Johnson Yiu Nam, Director Granted 1 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Kwan Rudolf, EVP, Chief Medical Officer Granted 140,000 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Fok Manson, Director Granted 27,000 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Campbell Kim, Director Granted 30,000 Stock Option (Right to Buy)
21 Aug 2018	Form 4/A: Zhang Song-Yi, Director and 3 others Sold 42,113 shares ($751K) · Sold 43,845 shares ($725K) · Sold 61,207 shares ($1.02M)
14 May 2018	Form 4/A: Zhang Song-Yi, Director and 3 others Holds 678,880 shares of Common Stock
07 May 2018	Form 4/A: Zhang Song-Yi, Director and 3 others Disposed of 300,000 shares (Other Transaction) · Disposed of 60,000 shares (Other Transaction)
27 Apr 2018	Form 4/A: Zuo William Wei, President, China Granted 1 Stock Option (Right to Buy)
27 Apr 2018	Form 4/A: Zukin James, Director Granted 19,500 Stock Option (Right to Buy)

Comments